
Healthcare Monitor
- 55 installs
- 82 repo stars
- Updated August 2, 2026
- aaaaqwq/claude-code-skills
healthcare-monitor is a Claude Code skill that monitors Chinese healthcare companies' business-registry changes to detect and alert on funding signals.
About
healthcare-monitor is a skill that monitors Chinese healthcare companies for undisclosed funding signals. It periodically scrapes business-registry data (Tianyancha/Qichacha) via Playwright, does incremental change detection, and scores signals like new institutional shareholders or registered-capital increases into confidence-weighted funding alerts. It pushes alerts to Telegram and Feishu and generates daily and weekly reports. It is used by media, VC/PE and pharma BD teams to spot funding leads early.
- Monitors Chinese healthcare companies' business-registry changes to detect funding signals
- Scrapes Tianyancha/Qichacha via Playwright and scores change signals into confidence-weighted alerts
- Pushes alerts to Telegram and Feishu and generates daily/weekly reports
Healthcare Monitor by the numbers
- 55 all-time installs (skills.sh)
- Ranked #1,047 of 2,719 Automation & Workflows skills by installs in the Skillselion catalog
- Data as of Aug 3, 2026 (Skillselion catalog sync)
healthcare-monitor capabilities & compatibility
- Capabilities
- web scraping · monitoring · data analysis
- Works with
- playwright
- Use cases
- web scraping · data analysis · research
- Pricing
- Free
What healthcare-monitor says it does
医疗行业企业融资监控系统。实时监控医疗健康企业的工商变更,识别融资信号
allowed-tools: Bash, Read, Write, Edit, Exec, Browser, Message, Cron
npx skills add https://github.com/aaaaqwq/claude-code-skills --skill healthcare-monitorAdd your badge
Show developers this skill is listed on Skillselion. Paste this into your README.
| Installs | 55 |
|---|---|
| repo stars | ★ 82 |
| Last updated | August 2, 2026 |
| Repository | aaaaqwq/claude-code-skills ↗ |
What it does
Use it to monitor healthcare companies' registry changes and get scored funding-signal alerts and reports.
Who is it for?
Early detection of undisclosed healthcare-company funding events for media, VC/PE and pharma BD.
Skip if: General agent building, non-China markets, or use cases without web-registry scraping.
When should I use this skill?
The user wants to monitor company registry changes and get funding-signal alerts.
What you get
Confidence-scored funding alerts pushed to chat, plus daily/weekly monitoring reports.
- Confidence-scored funding-signal alerts
- Daily and weekly monitoring reports
By the numbers
- 3-tier signal scoring (strong/medium/weak) with weighted confidence
- check intervals of 1h/6h/24h by priority
Files
医疗行业企业融资监控系统
概述
本技能实现医疗健康行业企业的融资信号实时监控,通过工商变更数据识别未披露的融资事件,为媒体、投资机构提供情报服务。
核心功能
1. 企业监控列表管理
- 添加/删除监控企业
- 按行业、地区、规模分类
- 设置监控优先级
2. 工商变更检测
- 定时爬取天眼查/企查查
- 增量对比检测变更
- 识别关键变更类型
3. 融资信号识别
- AI 判断是否为融资
- 融资轮次推断
- 投资方识别
4. 多渠道推送
- Telegram 实时告警
- 飞书群组推送
- 日报/周报生成
文件结构
skills/healthcare-monitor/
├── SKILL.md # 技能说明
├── config/
│ ├── companies.json # 监控企业列表
│ └── settings.json # 配置参数
├── scripts/
│ ├── monitor.py # 主监控脚本
│ ├── scraper.py # 数据采集
│ ├── analyzer.py # 融资分析
│ └── notifier.py # 推送通知
├── data/
│ ├── snapshots/ # 企业快照
│ ├── changes/ # 变更记录
│ └── reports/ # 生成的报告
└── templates/
├── alert.md # 告警模板
└── daily_report.md # 日报模板快速开始
1. 添加监控企业
# 添加单个企业
python3 ~/clawd/skills/healthcare-monitor/scripts/monitor.py add "北京某某医疗科技有限公司"
# 批量导入
python3 ~/clawd/skills/healthcare-monitor/scripts/monitor.py import companies.csv2. 手动检查
# 检查所有企业
python3 ~/clawd/skills/healthcare-monitor/scripts/monitor.py check
# 检查单个企业
python3 ~/clawd/skills/healthcare-monitor/scripts/monitor.py check "公司名称"3. 设置定时任务
# 每小时检查重点企业
# 使用 OpenClaw cron 工具设置融资信号识别规则
强信号 (置信度 >80%)
| 信号 | 描述 | 权重 |
|---|---|---|
| 新增机构股东 | 股东名称包含"投资/资本/基金/创投" | +40 |
| 注册资本增加 | 增幅 >10% | +30 |
| 股权稀释 | 创始人持股比例下降 | +20 |
中信号 (置信度 50-80%)
| 信号 | 描述 | 权重 |
|---|---|---|
| 新增自然人股东 | 可能是投资人代持 | +15 |
| 经营范围扩大 | 业务扩张信号 | +10 |
| 办公地址变更 | 搬迁到更好区域 | +10 |
弱信号 (置信度 <50%)
| 信号 | 描述 | 权重 |
|---|---|---|
| 仅注册资本增加 | 可能是内部增资 | +10 |
| 法人变更 | 可能是内部调整 | +5 |
融资轮次判断
种子/天使轮:
- 公司成立 <2 年
- 注册资本 <500 万
- 新股东为天使投资人
A轮:
- 公司成立 2-4 年
- 注册资本增幅 20-50%
- 新股东为知名 VC
B轮+:
- 公司成立 >3 年
- 注册资本增幅 10-30%
- 新股东为大型 PE/战略投资者数据采集
天眼查采集
# 采集字段
fields = {
"basic": ["公司名称", "法人", "注册资本", "成立日期", "经营状态"],
"shareholders": ["股东名称", "持股比例", "认缴出资", "出资日期"],
"changes": ["变更时间", "变更项目", "变更前", "变更后"],
"investments": ["被投企业", "投资金额", "投资时间"],
}反爬策略
策略:
- 使用 Playwright 无头浏览器
- 随机延迟 3-10 秒
- 轮换 User-Agent
- 代理 IP 池 (可选)
- 模拟人类行为 (滚动、点击)
限制:
- 每小时最多 100 次请求
- 单企业每天最多查询 3 次
- 遇到验证码暂停并告警推送配置
Telegram 推送
{
"telegram": {
"enabled": true,
"bot_token": "从 config 读取",
"chat_id": "REDACTED_TG_USER_ID",
"alert_level": "high"
}
}飞书推送
{
"feishu": {
"enabled": true,
"webhook": "从 config 读取",
"alert_level": "all"
}
}告警模板
融资告警
🚨 **融资信号告警**
**企业**: {{company_name}}
**变更时间**: {{change_date}}
**置信度**: {{confidence}}%
**变更详情**:
- 注册资本: {{old_capital}} → {{new_capital}}
- 新增股东: {{new_shareholders}}
- 股权变化: {{equity_changes}}
**AI 分析**:
- 融资轮次: {{round_estimate}}
- 融资金额: {{amount_estimate}}
- 投资方: {{investors}}
**数据来源**: 天眼查
**监控时间**: {{monitor_time}}API 接口
查询企业状态
GET /api/company/{company_name}
Response:
{
"name": "公司名称",
"last_check": "2026-02-03 22:00:00",
"status": "normal",
"recent_changes": [...],
"funding_signals": [...]
}添加监控
POST /api/monitor
{
"company_name": "公司名称",
"priority": "high",
"check_interval": "hourly"
}使用场景
场景一: 媒体情报
动脉网等医疗媒体使用,第一时间获取融资新闻线索。
工作流:
1. 系统检测到融资信号
2. 推送到编辑 Telegram
3. 编辑核实后发布新闻
4. 比竞争对手快 24-48 小时场景二: 投资机构
VC/PE 使用,发现潜在投资标的或跟投机会。
工作流:
1. 系统检测到 A 轮融资
2. 推送到投资经理
3. 评估是否跟进
4. 主动联系企业场景三: 大药企 BD
药企商务拓展部门使用,寻找合作/收购标的。
工作流:
1. 系统检测到目标领域企业融资
2. 推送到 BD 团队
3. 评估合作可能性
4. 发起商务接触监控企业列表 (初始)
医疗器械
- 迈瑞医疗
- 联影医疗
- 微创医疗
- 先瑞达医疗
- 心脉医疗
创新药
- 百济神州
- 信达生物
- 君实生物
- 再鼎医药
- 和黄医药
医疗AI
- 推想科技
- 数坤科技
- 深睿医疗
- 汇医慧影
- 医渡云
互联网医疗
- 微医集团
- 丁香园
- 春雨医生
- 好大夫在线
- 平安好医生
基因检测
- 华大基因
- 贝瑞基因
- 燃石医学
- 泛生子
- 诺禾致源
配置参数
{
"check_interval": {
"high_priority": "1h",
"normal": "6h",
"low": "24h"
},
"alert_threshold": {
"confidence": 60,
"capital_change_percent": 10
},
"scraper": {
"delay_min": 3,
"delay_max": 10,
"max_requests_per_hour": 100
},
"notification": {
"telegram": true,
"feishu": true,
"email": false
}
}故障排查
问题: 爬取失败
# 检查日志
tail -f ~/clawd/skills/healthcare-monitor/data/logs/scraper.log
# 常见原因
- IP 被封: 更换代理
- 验证码: 人工处理或接入打码平台
- 页面结构变化: 更新选择器问题: 误报过多
# 调整置信度阈值
# 编辑 config/settings.json
{
"alert_threshold": {
"confidence": 70 # 提高阈值
}
}相关文件
~/clawd/docs/solutions/healthcare-data-intelligence.md- 完整解决方案~/.openclaw/agents/healthcare-monitor/- Agent 配置~/clawd/skills/healthcare-monitor/data/- 数据存储
TODO
- [ ] 实现天眼查爬虫
- [ ] 实现融资信号 AI 分析
- [ ] 设置定时任务
- [ ] 对接飞书推送
- [ ] 添加 Web 管理界面
- [ ] 支持更多数据源 (企查查、启信宝)
- [ ] 实现日报/周报自动生成
{
"priority_high": [
{"name": "迈瑞医疗", "industry": "医疗器械", "focus": "IVD、影像、生命信息支持"},
{"name": "联影医疗", "industry": "医疗器械", "focus": "高端医学影像设备"},
{"name": "百济神州", "industry": "创新药", "focus": "抗肿瘤药"},
{"name": "信达生物", "industry": "创新药", "focus": "单抗、双抗"},
{"name": "君实生物", "industry": "创新药", "focus": "PD-1、创新药"}
],
"priority_normal": [
{"name": "再鼎医药", "industry": "创新药", "focus": "抗肿瘤、抗感染"},
{"name": "和黄医药", "industry": "创新药", "focus": "靶向治疗"},
{"name": "推想医疗", "industry": "医疗AI", "focus": "医学影像AI"},
{"name": "数坤科技", "industry": "医疗AI", "focus": "心血管AI"},
{"name": "深睿医疗", "industry": "医疗AI", "focus": "AI辅助诊断"}
],
"priority_low": []
}
{
"check_interval": {
"high_priority": "1h",
"normal": "6h",
"low": "24h"
},
"alert_threshold": {
"confidence": 60,
"capital_change_percent": 10
},
"scraper": {
"delay_min": 3,
"delay_max": 10,
"max_requests_per_hour": 100
},
"notification": {
"telegram": true,
"feishu": false
},
"data_sources": ["tianyancha", "qcc"]
}
{"company_name": "信达生物", "confidence": 35, "signals": [{"type": "new_shareholder", "strength": "medium", "detail": "新增股东: 创始股东A"}, {"type": "new_shareholder", "strength": "medium", "detail": "新增股东: 创始股东B"}, {"type": "legal_person_change", "strength": "weak", "detail": "法人变更: None → 示例法人"}], "timestamp": "2026-02-19T09:03:23.756250"}
{"company_name": "推想医疗", "confidence": 35, "signals": [{"type": "new_shareholder", "strength": "medium", "detail": "新增股东: 创始股东A"}, {"type": "new_shareholder", "strength": "medium", "detail": "新增股东: 创始股东B"}, {"type": "legal_person_change", "strength": "weak", "detail": "法人变更: None → 示例法人"}], "timestamp": "2026-02-19T09:03:32.351718"}
{"company_name": "百济神州", "confidence": 35, "signals": [{"type": "new_shareholder", "strength": "medium", "detail": "新增股东: 创始股东A"}, {"type": "new_shareholder", "strength": "medium", "detail": "新增股东: 创始股东B"}, {"type": "legal_person_change", "strength": "weak", "detail": "法人变更: None → 示例法人"}], "timestamp": "2026-02-19T09:03:23.754279"}
{"company_name": "联影医疗", "confidence": 35, "signals": [{"type": "new_shareholder", "strength": "medium", "detail": "新增股东: 创始股东A"}, {"type": "new_shareholder", "strength": "medium", "detail": "新增股东: 创始股东B"}, {"type": "legal_person_change", "strength": "weak", "detail": "法人变更: None → 示例法人"}], "timestamp": "2026-02-19T09:03:23.752820"}
{"company_name": "迈瑞医疗", "confidence": 35, "signals": [{"type": "new_shareholder", "strength": "medium", "detail": "新增股东: 创始股东A"}, {"type": "new_shareholder", "strength": "medium", "detail": "新增股东: 创始股东B"}, {"type": "legal_person_change", "strength": "weak", "detail": "法人变更: None → 示例法人"}], "timestamp": "2026-02-19T09:03:23.749253"}
{
"date": "2026-02-06",
"total": 10,
"checked": 10,
"signals_found": 9,
"high_confidence": 6,
"companies": [
{
"company": "迈瑞医疗",
"has_signal": false,
"confidence": 10,
"sources_count": 1,
"sources": [
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "[PDF] 深圳迈瑞生物医疗电子股份有限公司 - Mindray",
"url": "https://www.mindray.com/content/dam/xpace/zh/investor-relations/financialinformation/2020/Mindray_2020_AnnualReport.pdf",
"keywords": [
"融资"
],
"investors": [],
"confidence": 10
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "迈瑞医疗:预计国内业务2026年全年有望实现正增长",
"url": "https://innomd.com/article/0246ec5569171c56ea1a0123ab622b5d.html",
"keywords": [
"融资"
],
"investors": [],
"confidence": 10
}
],
"checked_at": "2026-02-06T14:31:20.221936",
"category": "医疗器械",
"priority": "high"
},
{
"company": "联影医疗",
"has_signal": true,
"confidence": 61,
"sources_count": 2,
"sources": [
"Firecrawl",
"新浪财经"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "联影智能完成10亿元A轮融资,医疗AI大模型与智能体研发加速 - 医谷",
"url": "https://m.medvalley.cn/article/224-0-77456",
"keywords": [
"融资",
"投资",
"A轮",
"领投"
],
"investors": [
"金管理有限公司和上国投资",
"本次融资由易方达私募基金"
],
"confidence": 95,
"round": "A轮",
"amount": "10亿元"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "央山医疗完成数千万元preA轮融资山蓝、远毅联合领投",
"url": "https://finance.sina.com.cn/stock/estate/integration/2026-02-06/doc-inhkvvnp5208906.shtml",
"keywords": [
"融资",
"投资",
"A轮",
"领投",
"跟投"
],
"investors": [
"远毅资本",
"蓝驰创投",
"不构成投资",
"本轮融资由医疗专业投资",
"医疗专业投资机构山蓝资本"
],
"confidence": 95,
"round": "A轮"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "中金公司助力联影智能完成10亿元A轮融资,推动医疗AI产业升级",
"url": "https://www.cicc.com/news/details311_132216.html",
"keywords": [
"融资",
"A轮"
],
"investors": [],
"confidence": 55,
"round": "A轮",
"amount": "10亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "完成10 亿融资,联影智能「元智」领跑医疗大模型排名",
"url": "https://www.uii-ai.com/article/409.html",
"keywords": [
"融资",
"A轮"
],
"investors": [],
"confidence": 55,
"round": "A轮",
"amount": "10亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "机器人、生物医药赛道融资活跃,联影智能完成10亿元A轮融资 - 21财经",
"url": "https://www.21jingji.com/article/20250623/herald/a5517493cf2a0ac7c47702b8c9cf46d0.html",
"keywords": [
"融资",
"A轮"
],
"investors": [],
"confidence": 55,
"round": "A轮",
"amount": "10亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "10亿融资!又一家百亿独角兽诞生 - ByDrug - 医药魔方",
"url": "https://bydrug.pharmcube.com/news/detail/84b1a7cf3a715315b0c4cde5d511f049",
"keywords": [
"融资",
"投资"
],
"investors": [
"联影医疗拟以自有资金投资"
],
"confidence": 48,
"amount": "10亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "主业承压却豪赌AI,联影医疗组百亿生态局-36氪",
"url": "https://m.36kr.com/p/3363697947400328",
"keywords": [
"融资",
"增资",
"估值"
],
"investors": [],
"confidence": 45,
"amount": "100亿元"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "爱尔眼科(300015.SZ)澄清:与湖南恒泰康康复医疗产业发展有限公司及其下属机构不存在股权控制、业务关联或经营管理关系",
"url": "https://finance.sina.com.cn/stock/bxjj/2026-02-06/doc-inhkvzum5138296.shtml",
"keywords": [
"投资"
],
"investors": [
"爱尔医疗投资",
"是爱尔医疗投资与其他投资"
],
"confidence": 28
}
],
"checked_at": "2026-02-06T14:31:25.765880",
"category": "医疗器械",
"priority": "high"
},
{
"company": "百济神州",
"has_signal": true,
"confidence": 51,
"sources_count": 1,
"sources": [
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "百济神州争流史 - 知乎专栏",
"url": "https://zhuanlan.zhihu.com/p/506249883",
"keywords": [
"融资",
"投资",
"B轮"
],
"investors": [
"多起投资"
],
"confidence": 78,
"round": "B轮",
"amount": "292.08亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "出海浪潮下的资本创新:详解百济神州8.85亿美元RBF交易战略",
"url": "https://www.cbpfcn.com/news/5937",
"keywords": [
"融资",
"投资"
],
"investors": [
"出海浪潮下的资本",
"百济神州与专业特许权投资"
],
"confidence": 61,
"amount": "8.85亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "8年狂砸700亿搞研发百济神州亟需盈利补现 - 新浪财经",
"url": "https://finance.sina.com.cn/zmt/2025-03-04/doc-inennqmp5380202.shtml",
"keywords": [
"融资"
],
"investors": [
"百济神州未来资本"
],
"confidence": 58,
"round": "上市",
"amount": "700亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "百济神州| 项目信息-36氪 - 创投平台",
"url": "https://pitchhub.36kr.com/project/1679650373096194",
"keywords": [
"融资"
],
"investors": [],
"confidence": 33,
"amount": "20.8亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "百济神州合作方获10亿融资,RNA药物或再迎风口",
"url": "https://www.phirda.com/artilce_40448.html?module=trackingCodeGenerator",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "14.5亿美元"
}
],
"checked_at": "2026-02-06T14:31:32.210918",
"category": "创新药",
"priority": "high"
},
{
"company": "信达生物",
"has_signal": true,
"confidence": 45,
"sources_count": 2,
"sources": [
"Firecrawl",
"新浪财经"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "信达生物| 项目信息-36氪 - 创投平台",
"url": "https://pitchhub.36kr.com/project/1678290670580739",
"keywords": [
"融资",
"D轮",
"E轮",
"股权融资",
"IPO"
],
"investors": [],
"confidence": 93,
"round": "E轮",
"amount": "1.5亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "现有主要投资者 - 信达生物制药",
"url": "https://investor.innoventbio.com/cn/investors/current-key-investors",
"keywords": [
"融资",
"投资"
],
"investors": [
"现有主要投资",
"国制药行业最大的私募资本",
"得到国际顶级资本",
"形成了利用全球资本"
],
"confidence": 71,
"amount": "5.8亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "信达生物- 维基百科,自由的百科全书",
"url": "https://zh.wikipedia.org/zh-hans/%E4%BF%A1%E9%81%94%E7%94%9F%E7%89%A9",
"keywords": [
"融资",
"A轮",
"B轮"
],
"investors": [],
"confidence": 65,
"round": "A轮",
"amount": "1000万美元"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "前信达生物高管创业,拿下4.3亿元融资",
"url": "https://k.sina.com.cn/article_5953466437_162dab04506709nlow.html",
"keywords": [
"融资"
],
"investors": [
"三星风投",
"制药等国内外知名产业资本"
],
"confidence": 51,
"amount": "4.3亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "超43亿港元!信达生物配股融资持续推动全球研发布局 - 医药魔方",
"url": "https://www.pharmcube.com/newsLibrary/detail?id=fe91ce5b8288faf2d7f3a0762c6af1f6",
"keywords": [
"融资",
"投资"
],
"investors": [
"机构或其他投资"
],
"confidence": 48,
"amount": "43亿"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "信达生物亮剑了!全球首款双靶点减肥药获批,43亿港元融资抢滩全球市场!",
"url": "https://k.sina.com.cn/article_5953466437_162dab04506708fmnu.html",
"keywords": [
"融资"
],
"investors": [],
"confidence": 45,
"round": "上市",
"amount": "43亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "信达融资5.5 亿美元,剑指全球化",
"url": "https://www.phirda.com/artilce_39346.html?module=trackingCodeGenerator",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "5.5亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "[PDF] 信达生物制药集团2025年度期中业绩报告",
"url": "https://investor.innoventbio.com/media/1324/%E4%BF%A1%E8%BE%BE%E7%94%9F%E7%89%A9_2025%E5%8D%8A%E5%B9%B4%E5%BA%A6%E4%B8%9A%E7%BB%A9%E5%85%AC%E5%91%8A_%E6%8C%82%E7%BD%91%E7%89%88.pdf",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "10亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "信达生物超43亿港元配股融资,全球研发战略再升级 - 智慧芽",
"url": "https://www.zhihuiya.com/news/info_9651.html",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "43亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "信达生物折价配股募资约43亿港元近期多家头部药企再融资动作频频",
"url": "https://www.stcn.com/article/detail/2285162.html",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "43亿"
}
],
"checked_at": "2026-02-06T14:31:36.494707",
"category": "创新药",
"priority": "high"
},
{
"company": "推想科技",
"has_signal": true,
"confidence": 95,
"sources_count": 2,
"sources": [
"Firecrawl",
"新浪财经"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "【独家】推想科技获红杉领投5000万A轮融资,人工智能开年受宠-36氪",
"url": "https://m.36kr.com/p/1721200181249",
"keywords": [
"融资",
"投资",
"A轮",
"领投",
"跟投"
],
"investors": [
"本轮投资",
"推想科技获红杉",
"本轮投资由红杉",
"上一轮投资人英诺天使基金",
"本轮投资由红杉资本"
],
"confidence": 95,
"round": "A轮",
"amount": "5000万"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "推想科技完成1.2亿元B轮融资,泰合资本担任独家财务顾问",
"url": "https://www.taihecap.com/news_list_show-9-321.html",
"keywords": [
"融资",
"投资",
"B轮",
"领投"
],
"investors": [
"红杉中国联合投资",
"泰合资本",
"元生资本",
"由启明创投"
],
"confidence": 95,
"round": "B轮",
"amount": "1.2亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "1.16融资清单:推想科技完成A轮融资,金额5000万人民币",
"url": "https://m.cyzone.cn/article/157052",
"keywords": [
"融资",
"投资",
"A轮"
],
"investors": [
"投资方红杉",
"投资方红杉资本中国基金",
"投资方红杉资本",
"臻云创投",
"英诺天使基金"
],
"confidence": 95,
"round": "A轮",
"amount": "5000万人民币"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "推想科技完成1250万天使轮融资 - 动脉网",
"url": "https://www.vbdata.cn/intelDetail/537844",
"keywords": [
"融资",
"投资",
"天使轮"
],
"investors": [
"臻云创投",
"投资机构包括英诺天使基金"
],
"confidence": 95,
"round": "天使轮",
"amount": "1250万"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "私募通数据日报:医学AI公司推想科技获1.2亿元B轮融资 - 界面新闻",
"url": "https://m.jiemian.com/article/1643043.html",
"keywords": [
"融资",
"投资",
"B轮",
"领投"
],
"investors": [
"本轮融资由启明",
"红杉中国联合投资",
"本轮融资由启明创投",
"元生资本"
],
"confidence": 95,
"round": "B轮",
"amount": "1.2亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "【熵周刊】推想科技完成3亿元C轮融资美年战略投资智云健康",
"url": "http://www.cn-healthcare.com/api/third/article/501696",
"keywords": [
"融资",
"投资",
"C轮",
"天使轮",
"战略投资"
],
"investors": [
"广发乾和以及英诺天使基金",
"月完成由红杉",
"臻云创投",
"轮融资美年战略投资",
"月完成由红杉资本"
],
"confidence": 95,
"round": "天使轮",
"amount": "3亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "启明创投投资企业推想医疗完成D2轮融资,入选联合国全球医药设备 ...",
"url": "https://www.qimingvc.com/cn/news/%E5%90%AF%E6%98%8E%E6%98%9F-%E5%90%AF%E6%98%8E%E5%88%9B%E6%8A%95%E6%8A%95%E8%B5%84%E4%BC%81%E4%B8%9A%E6%8E%A8%E6%83%B3%E5%8C%BB%E7%96%97%E5%AE%8C%E6%88%90d2%E8%BD%AE%E8%9E%8D%E8%B5%84%EF%BC%8C%E5%85%A5%E9%80%89%E8%81%94%E5%90%88%E5%9B%BD%E5%85%A8%E7%90%83%E5%8C%BB%E8%8D%AF%E8%AE%BE%E5%A4%87%E9%87%87%E8%B4%AD%E5%90%8D%E5%BD%95",
"keywords": [
"融资",
"投资",
"D轮"
],
"investors": [
"启明创投投资",
"启明创投",
"投资方包括启峰资本"
],
"confidence": 95,
"round": "D轮",
"amount": "9亿人民币"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "生数科技完成超6亿元A+轮融资创国内视频生成领域最大单笔融资",
"url": "https://cj.sina.com.cn/articles/view/5597884738/14da8f142020021tc8",
"keywords": [
"融资",
"投资",
"战略投资",
"领投"
],
"investors": [
"星连资本",
"觉中国等上市公司战略投资"
],
"confidence": 95,
"round": "A+轮",
"amount": "6亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "推想科技完成9亿人民币D+轮融资- 资本- 亿邦动力",
"url": "https://www.ebrun.com/20210723/444883.shtml",
"keywords": [
"融资",
"投资"
],
"investors": [
"启峰资本",
"中关村并购母基金"
],
"confidence": 89,
"round": "D+轮",
"amount": "9亿人民币"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "关于我们-推想医疗科技股份有限公司-致力成为全院级AI品牌",
"url": "https://www.infervision.com/about.html",
"keywords": [
"融资",
"A轮",
"B轮",
"C轮",
"天使轮"
],
"investors": [],
"confidence": 70,
"round": "天使轮"
}
],
"checked_at": "2026-02-06T14:31:42.217495",
"category": "医疗AI",
"priority": "high"
},
{
"company": "数坤科技",
"has_signal": true,
"confidence": 74,
"sources_count": 2,
"sources": [
"Firecrawl",
"新浪财经"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "1年2次融资过亿元,受资本青睐的数坤科技切中了行业什么痛点?",
"url": "https://m.cyzone.cn/article/187038",
"keywords": [
"融资",
"投资",
"A轮",
"天使轮"
],
"investors": [
"万元天使轮投资",
"月远毅资本",
"由华盖资本"
],
"confidence": 95,
"round": "天使轮",
"amount": "2200万元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "数坤科技正式递表港交所:上半年亏损7500万元,红杉等为股东 - Bilibili",
"url": "https://www.bilibili.com/read/cv13277825",
"keywords": [
"融资",
"领投",
"IPO"
],
"investors": [
"其完成红杉",
"其完成红杉资本",
"其完成红杉资本中国基金"
],
"confidence": 95,
"round": "IPO",
"amount": "4亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "数坤科技重启IPO 深度布局人工智能医学影像解决方案 - 证券时报",
"url": "https://www.stcn.com/article/detail/787173.html?u_atoken=d45812685b6b86629b14da1c9dd4a3ee&u_asig=ffbfd",
"keywords": [
"融资",
"投资",
"D轮",
"IPO"
],
"investors": [
"春华资本",
"该轮融资投资"
],
"confidence": 95,
"round": "D轮",
"amount": "7亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "关于数坤-数坤科技官方网站",
"url": "https://www.shukun.com/about.html",
"keywords": [
"融资",
"投资",
"领投"
],
"investors": [
"春华资本",
"红杉资本",
"红杉资本中国基金",
"简街资本",
"简街资本等联合投资"
],
"confidence": 87
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "数坤科技已完成新一轮数亿元融资,闯关IPO后能否杀死比赛? - 知乎",
"url": "https://zhuanlan.zhihu.com/p/1969432046729401148",
"keywords": [
"融资",
"领投",
"IPO"
],
"investors": [
"年官宣获得红杉"
],
"confidence": 78,
"round": "IPO",
"amount": "5.9亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "独家|AI医疗影像独角兽数坤科技再冲IPO - 新浪财经",
"url": "https://finance.sina.com.cn/jjxw/2025-11-03/doc-infwaxxx1471525.shtml",
"keywords": [
"融资",
"D轮",
"估值",
"IPO"
],
"investors": [],
"confidence": 75,
"round": "D轮",
"amount": "94亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "数坤科技再启IPO估值曾达94亿元 - 观点网",
"url": "https://www.guandian.cn/article/20251103/521415.html",
"keywords": [
"融资",
"D轮",
"估值",
"IPO"
],
"investors": [],
"confidence": 75,
"round": "D轮",
"amount": "94亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "独家|AI医疗影像独角兽数坤科技再冲IPO - ByDrug",
"url": "https://bydrug.pharmcube.com/news/detail/39595bc3c75acd03b6628758d780ca83",
"keywords": [
"融资",
"D轮",
"估值",
"IPO"
],
"investors": [],
"confidence": 75,
"round": "D轮",
"amount": "94亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "数坤科技| 项目信息-36氪 - 创投平台",
"url": "https://pitchhub.36kr.com/project/1678464291927042",
"keywords": [
"融资",
"领投"
],
"investors": [
"启明创投"
],
"confidence": 56,
"amount": "2亿元"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "打造半导体设备国产“强心脏”,槃实科技完成亿元级A轮融资",
"url": "https://t.cj.sina.com.cn/articles/view/1960136440/74d54ef8001025cr8",
"keywords": [
"融资",
"A轮"
],
"investors": [],
"confidence": 40,
"round": "A轮"
}
],
"checked_at": "2026-02-06T14:31:48.478153",
"category": "医疗AI",
"priority": "high"
},
{
"company": "微医集团",
"has_signal": true,
"confidence": 64,
"sources_count": 1,
"sources": [
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "估值480亿独角兽,再闯港交所 - 投中网",
"url": "https://www.chinaventure.com.cn/news/111-20250102-384579.html",
"keywords": [
"融资",
"投资",
"估值",
"IPO"
],
"investors": [
"红杉资本与千禧投资",
"红杉资本"
],
"confidence": 95,
"round": "Pre-I",
"amount": "4亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "微医控股IPO:AI“标签”含金量不足,连年亏损、实控人曾违规 - 维科号",
"url": "https://mp.ofweek.com/display/a156714320677",
"keywords": [
"融资",
"IPO"
],
"investors": [
"微医控股一直是资本"
],
"confidence": 76,
"round": "IPO",
"amount": "14.5亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "微医刚宣布:5亿美金Pre-IPO融资完成,估值55亿美元 - 界面新闻",
"url": "https://m.jiemian.com/article/2123201.html",
"keywords": [
"融资",
"领投",
"估值",
"IPO"
],
"investors": [],
"confidence": 75,
"round": "Pre-I",
"amount": "55亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "微医集团| 项目信息 - 创投平台- 36氪",
"url": "https://pitchhub.36kr.com/project/1713107181709832",
"keywords": [
"融资",
"股权融资",
"IPO"
],
"investors": [],
"confidence": 73,
"round": "Pre-I",
"amount": "4亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "单一客户营收占比超50% 微医再冲港股IPO - 中国经营网",
"url": "http://www.cb.com.cn/index/show/bzyc/cv/cv135242211641",
"keywords": [
"融资",
"估值",
"IPO"
],
"investors": [],
"confidence": 65,
"round": "G轮",
"amount": "67亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "微医再度递表港交所,G轮投后估值达67亿美元 - 医药魔方",
"url": "https://www.pharmcube.com/newsLibrary/detail?id=bcde2acc93a678c247a6699985035ab9",
"keywords": [
"融资",
"估值"
],
"investors": [],
"confidence": 55,
"round": "G轮",
"amount": "67亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "技术霸榜、增长破局与现金流转正:微医控股完成关键一跃 - 中新经纬",
"url": "https://www.jwview.com/jingwei/html/m/02-03/657607.shtml",
"keywords": [
"融资",
"投资",
"估值"
],
"investors": [
"中新经纬"
],
"confidence": 51
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "硬核AI、高速增长与接近盈利:微医控股提速换挡解锁高质量发展",
"url": "https://finance.sina.cn/stock/jdts/2026-02-03/detail-inhkpeii0307892.d.html?vt=4&cid=76993&node_id=76993",
"keywords": [
"融资",
"投资",
"估值"
],
"investors": [],
"confidence": 38
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "微医_百度百科",
"url": "https://baike.baidu.com/item/%E5%BE%AE%E5%8C%BB/53194826",
"keywords": [
"投资"
],
"investors": [
"中投中财等知名机构投资",
"晨兴资本"
],
"confidence": 36
}
],
"checked_at": "2026-02-06T14:31:55.790620",
"category": "互联网医疗",
"priority": "high"
},
{
"company": "丁香园",
"has_signal": true,
"confidence": 85,
"sources_count": 2,
"sources": [
"Firecrawl",
"新浪财经"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "马化腾、雷军加持的丁香园,要赴港上市了?",
"url": "https://user.guancha.cn/main/content?id=1510808",
"keywords": [
"融资",
"投资",
"A轮",
"B轮",
"增资"
],
"investors": [
"市政府设立的创投引导基金",
"府设立的创投引导基金投资",
"中国投资",
"获得杭州市政府设立的创投"
],
"confidence": 95,
"round": "A轮",
"amount": "200万美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "丁香园完成5亿美元E轮融资 - 人民网",
"url": "http://capital.people.com.cn/n1/2020/1229/c406063-31983016.html",
"keywords": [
"融资",
"投资",
"E轮",
"领投",
"跟投"
],
"investors": [
"高瓴创投"
],
"confidence": 95,
"round": "E轮",
"amount": "5亿美元"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "三石园科技完成近亿元D轮融资",
"url": "https://finance.sina.com.cn/tech/roll/2026-02-05/doc-inhkucci5832897.shtml",
"keywords": [
"融资",
"D轮",
"领投",
"跟投"
],
"investors": [
"融资由中信金石和光合创投",
"静水湖创投",
"希扬资本",
"励石创投及老股东中南创投"
],
"confidence": 95,
"round": "D轮"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "放弃博士学位,50岁东北医生,干出一个IPO-36氪",
"url": "https://m.36kr.com/p/3461004933305987",
"keywords": [
"融资",
"投资",
"IPO"
],
"investors": [
"顺为资本",
"腾讯投资等机构的投资"
],
"confidence": 84,
"round": "IPO"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "49亿资本苦等15年,丁香园终于IPO?",
"url": "https://zhuanlan.zhihu.com/p/1949167130873426569",
"keywords": [
"融资",
"D轮",
"估值",
"IPO"
],
"investors": [],
"confidence": 83,
"round": "D轮",
"amount": "10亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "两次差点“夭折”,医疗独角兽丁香园创业故事",
"url": "https://m.cyzone.cn/article/579082",
"keywords": [
"融资",
"D轮",
"估值",
"IPO"
],
"investors": [],
"confidence": 75,
"round": "D轮",
"amount": "1亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "【熵周刊】丁香园估值达10亿美元百奥赛图获4.1亿元C轮融资",
"url": "http://www.cn-healthcare.com/api/third/article/502399",
"keywords": [
"融资",
"C轮",
"D轮",
"估值"
],
"investors": [],
"confidence": 75,
"round": "C轮",
"amount": "10亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "成立20年,丁香园终于要IPO!49亿资本的天终于要亮了? - 新浪财经",
"url": "https://cj.sina.cn/articles/view/5953189932/162d6782c067035sm0?froms=ggmp",
"keywords": [
"融资",
"D轮",
"IPO"
],
"investors": [],
"confidence": 73,
"round": "D轮",
"amount": "6.87亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "丁香园完成5亿美元融资,将持续巩固专业壁垒、加强“上游”布局",
"url": "https://m.ikanchai.com/pcarticle/400769",
"keywords": [
"融资",
"领投",
"跟投"
],
"investors": [
"高瓴创投"
],
"confidence": 66,
"amount": "5亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "丁香园完成5 亿美元融资,腾讯、高瓴创投参投",
"url": "https://www.ctoutiao.com/2814347.html",
"keywords": [
"融资",
"领投",
"跟投"
],
"investors": [
"高瓴创投"
],
"confidence": 66,
"amount": "5亿美元"
}
],
"checked_at": "2026-02-06T14:32:01.584311",
"category": "互联网医疗",
"priority": "high"
},
{
"company": "华大基因",
"has_signal": true,
"confidence": 35,
"sources_count": 1,
"sources": [
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "交易对价约3.66亿元,华大智造拟收购两大前沿业务 - 南方+",
"url": "https://www.nfnews.com/content/n614e1KO3P.html",
"keywords": [
"融资",
"估值"
],
"investors": [],
"confidence": 35,
"amount": "3.66亿元"
}
],
"checked_at": "2026-02-06T14:32:05.944437",
"category": "基因检测",
"priority": "high"
},
{
"company": "燃石医学",
"has_signal": true,
"confidence": 88,
"sources_count": 1,
"sources": [
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "燃石医学宣布完成C轮8.5亿人民币融资,打造国际领先的肿瘤精准 ...",
"url": "https://cn.lavfund.com/blog/c-8-5",
"keywords": [
"融资",
"投资",
"C轮",
"领投"
],
"investors": [
"礼来亚洲基金",
"新加坡政府投资",
"济峰资本"
],
"confidence": 95,
"round": "C轮",
"amount": "8.5亿人民币"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "燃石医学赴美IPO,四年亏损超5亿,基因检测公司盈利难在哪? - 36氪",
"url": "https://m.36kr.com/p/738133367825540",
"keywords": [
"融资",
"投资",
"IPO"
],
"investors": [
"比如红杉",
"投资方包括多家一线PE",
"北极光创投",
"比如红杉资本"
],
"confidence": 95,
"round": "IPO",
"amount": "2.4亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "燃石医学美国上市:市值25亿美元医疗已成热门投资赛道 - 新浪财经",
"url": "https://finance.sina.cn/hkstock/gggd/2020-06-13/detail-iirczymk6758582.d.html?vt=4",
"keywords": [
"融资",
"投资",
"B轮",
"C轮"
],
"investors": [
"亿美元医疗已成热门投资",
"新加坡政府投资",
"投资方包括红杉",
"投资方包括红杉资本",
"济峰资本"
],
"confidence": 95,
"round": "B轮",
"amount": "25亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "掘金下一片金矿:燃石医学闯关纳斯达克背后的资本故事- 21世纪经济 ...",
"url": "https://m.21jingji.com/article/20200618/5bf0c4d9e04d4c73d9fb9ae65c0d30fa_zaker.html",
"keywords": [
"融资",
"投资",
"IPO"
],
"investors": [
"红杉资本",
"红杉资本中国基金",
"华的投资人团队囊括了北极光",
"济峰资本",
"学闯关纳斯达克背后的资本"
],
"confidence": 95,
"round": "IPO",
"amount": "2亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "燃石医学获得B轮3亿元人民币融资_ 企业新闻_ 社区_ 小桔灯网_ 体外 ...",
"url": "https://www.iivd.net/thread-35203-1-1.html",
"keywords": [
"融资",
"投资",
"B轮"
],
"investors": [
"投资方包括红杉",
"投资方包括红杉资本",
"济峰资本"
],
"confidence": 95,
"round": "B轮",
"amount": "3亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "燃石医学获3亿元B轮融资,资本助力肿瘤医疗_CACLP体外诊断资讯网",
"url": "https://www.caclp.cn/article/?detail_1991.html",
"keywords": [
"融资",
"B轮"
],
"investors": [
"融资方包括红杉",
"济峰资本",
"融资方包括红杉资本"
],
"confidence": 86,
"round": "B轮",
"amount": "3亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "来自NGS一哥的教训:不要在谷底,才想起来跑得太快了 - OFweek",
"url": "https://m.ofweek.com/medical/2024-02/ART-11163-8420-30626683.html",
"keywords": [
"融资",
"IPO"
],
"investors": [
"更是成功抓住资本"
],
"confidence": 68,
"round": "IPO",
"amount": "2.4亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "总融资额超13亿的燃石医学为何成为投资人眼里的香饽饽? - 动脉网",
"url": "https://www.vbdata.cn/40964",
"keywords": [
"融资",
"投资"
],
"investors": [
"资便得到了联想之星和北极光",
"亿的燃石医学为何成为投资"
],
"confidence": 61,
"amount": "13亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "圣诺医药融资2.08亿港币;燃石医学第二季度亏损970万元港股创新药 ...",
"url": "https://xueqiu.com/7006267479/351687981",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "2.08亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "圣诺医药融资2.08亿港币;燃石医学第二季度亏损970万元 - ByDrug",
"url": "https://bydrug.pharmcube.com/news/detail/1b0409c40383aebf8f5300767d8b3f7a",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "2.08亿"
}
],
"checked_at": "2026-02-06T14:32:11.431059",
"category": "基因检测",
"priority": "high"
}
]
}{
"date": "2026-02-07",
"total": 10,
"checked": 10,
"signals_found": 9,
"high_confidence": 4,
"companies": [
{
"company": "迈瑞医疗",
"has_signal": false,
"confidence": 10,
"sources_count": 1,
"sources": [
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "[PDF] 深圳迈瑞生物医疗电子股份有限公司 - Mindray",
"url": "https://www.mindray.com/content/dam/xpace/zh/investor-relations/financialinformation/2020/Mindray_2020_AnnualReport.pdf",
"keywords": [
"融资"
],
"investors": [],
"confidence": 10
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "迈瑞医疗:预计国内业务2026年全年有望实现正增长",
"url": "https://innomd.com/article/0246ec5569171c56ea1a0123ab622b5d.html",
"keywords": [
"融资"
],
"investors": [],
"confidence": 10
}
],
"checked_at": "2026-02-07T12:47:04.350456",
"category": "医疗器械",
"priority": "high"
},
{
"company": "联影医疗",
"has_signal": true,
"confidence": 57,
"sources_count": 2,
"sources": [
"新浪财经",
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "联影智能完成10亿元A轮融资,医疗AI大模型与智能体研发加速 - 医谷",
"url": "https://m.medvalley.cn/article/224-0-77456",
"keywords": [
"融资",
"投资",
"A轮",
"领投"
],
"investors": [
"本次融资由易方达私募基金",
"金管理有限公司和上国投资"
],
"confidence": 95,
"round": "A轮",
"amount": "10亿元"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "财联社创投通:一级市场本周融资总额约121.83亿元环比增加38.65% 先进制造活跃度居前",
"url": "https://finance.sina.com.cn/roll/2026-02-07/doc-inhkxymr1497276.shtml",
"keywords": [
"融资",
"投资"
],
"investors": [
"财联社创投"
],
"confidence": 56,
"amount": "121.83亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "中金公司助力联影智能完成10亿元A轮融资,推动医疗AI产业升级",
"url": "https://www.cicc.com/news/details311_132216.html",
"keywords": [
"融资",
"A轮"
],
"investors": [],
"confidence": 55,
"round": "A轮",
"amount": "10亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "完成10 亿融资,联影智能「元智」领跑医疗大模型排名",
"url": "https://www.uii-ai.com/article/409.html",
"keywords": [
"融资",
"A轮"
],
"investors": [],
"confidence": 55,
"round": "A轮",
"amount": "10亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "机器人、生物医药赛道融资活跃,联影智能完成10亿元A轮融资 - 21财经",
"url": "https://www.21jingji.com/article/20250623/herald/a5517493cf2a0ac7c47702b8c9cf46d0.html",
"keywords": [
"融资",
"A轮"
],
"investors": [],
"confidence": 55,
"round": "A轮",
"amount": "10亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "10亿融资!又一家百亿独角兽诞生 - ByDrug - 医药魔方",
"url": "https://bydrug.pharmcube.com/news/detail/84b1a7cf3a715315b0c4cde5d511f049",
"keywords": [
"融资",
"投资"
],
"investors": [
"联影医疗拟以自有资金投资"
],
"confidence": 48,
"amount": "10亿"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "硬科技投向标|工信部:组织开展国家算力互联互通节点建设工作 北京人形完成首轮超7亿元融资",
"url": "https://finance.sina.com.cn/roll/2026-02-07/doc-inhkxucp7554533.shtml",
"keywords": [
"融资",
"投资"
],
"investors": [
"最新一轮融资中投资"
],
"confidence": 48,
"amount": "200亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "主业承压却豪赌AI,联影医疗组百亿生态局-36氪",
"url": "https://m.36kr.com/p/3363697947400328",
"keywords": [
"融资",
"增资",
"估值"
],
"investors": [],
"confidence": 45,
"amount": "100亿元"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "财联社创投通:一级市场本周117起融资环比减少11.36%,星思半导体完成近15亿元融资",
"url": "https://finance.sina.com.cn/jjxw/2026-02-07/doc-inhkxymm7440323.shtml",
"keywords": [
"融资"
],
"investors": [
"财联社创投",
"日讯据财联社创投"
],
"confidence": 43,
"amount": "15亿元"
}
],
"checked_at": "2026-02-07T12:47:08.935979",
"category": "医疗器械",
"priority": "high"
},
{
"company": "百济神州",
"has_signal": true,
"confidence": 51,
"sources_count": 1,
"sources": [
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "百济神州争流史 - 知乎专栏",
"url": "https://zhuanlan.zhihu.com/p/506249883",
"keywords": [
"融资",
"投资",
"B轮"
],
"investors": [
"多起投资"
],
"confidence": 78,
"round": "B轮",
"amount": "292.08亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "出海浪潮下的资本创新:详解百济神州8.85亿美元RBF交易战略",
"url": "https://www.cbpfcn.com/news/5937",
"keywords": [
"融资",
"投资"
],
"investors": [
"百济神州与专业特许权投资",
"出海浪潮下的资本"
],
"confidence": 61,
"amount": "8.85亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "8年狂砸700亿搞研发百济神州亟需盈利补现 - 新浪财经",
"url": "https://finance.sina.com.cn/zmt/2025-03-04/doc-inennqmp5380202.shtml",
"keywords": [
"融资"
],
"investors": [
"百济神州未来资本"
],
"confidence": 58,
"round": "上市",
"amount": "700亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "百济神州| 项目信息-36氪 - 创投平台",
"url": "https://pitchhub.36kr.com/project/1679650373096194",
"keywords": [
"融资"
],
"investors": [],
"confidence": 33,
"amount": "20.8亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "百济神州合作方获10亿融资,RNA药物或再迎风口",
"url": "https://www.phirda.com/artilce_40448.html?module=trackingCodeGenerator",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "14.5亿美元"
}
],
"checked_at": "2026-02-07T12:47:13.955536",
"category": "创新药",
"priority": "high"
},
{
"company": "信达生物",
"has_signal": true,
"confidence": 45,
"sources_count": 2,
"sources": [
"新浪财经",
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "信达生物| 项目信息-36氪 - 创投平台",
"url": "https://pitchhub.36kr.com/project/1678290670580739",
"keywords": [
"融资",
"D轮",
"E轮",
"股权融资",
"IPO"
],
"investors": [],
"confidence": 93,
"round": "E轮",
"amount": "1.5亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "现有主要投资者 - 信达生物制药",
"url": "https://investor.innoventbio.com/cn/investors/current-key-investors",
"keywords": [
"融资",
"投资"
],
"investors": [
"形成了利用全球资本",
"得到国际顶级资本",
"现有主要投资",
"国制药行业最大的私募资本"
],
"confidence": 71,
"amount": "5.8亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "信达生物- 维基百科,自由的百科全书",
"url": "https://zh.wikipedia.org/zh-hans/%E4%BF%A1%E9%81%94%E7%94%9F%E7%89%A9",
"keywords": [
"融资",
"A轮",
"B轮"
],
"investors": [],
"confidence": 65,
"round": "A轮",
"amount": "1000万美元"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "前信达生物高管创业,拿下4.3亿元融资",
"url": "https://k.sina.com.cn/article_5953466437_162dab04506709nlow.html",
"keywords": [
"融资"
],
"investors": [
"三星风投",
"制药等国内外知名产业资本"
],
"confidence": 51,
"amount": "4.3亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "超43亿港元!信达生物配股融资持续推动全球研发布局 - 医药魔方",
"url": "https://www.pharmcube.com/newsLibrary/detail?id=fe91ce5b8288faf2d7f3a0762c6af1f6",
"keywords": [
"融资",
"投资"
],
"investors": [
"机构或其他投资"
],
"confidence": 48,
"amount": "43亿"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "信达生物亮剑了!全球首款双靶点减肥药获批,43亿港元融资抢滩全球市场!",
"url": "https://k.sina.com.cn/article_5953466437_162dab04506708fmnu.html",
"keywords": [
"融资"
],
"investors": [],
"confidence": 45,
"round": "上市",
"amount": "43亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "信达融资5.5 亿美元,剑指全球化",
"url": "https://www.phirda.com/artilce_39346.html?module=trackingCodeGenerator",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "5.5亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "[PDF] 信达生物制药集团2025年度期中业绩报告",
"url": "https://investor.innoventbio.com/media/1324/%E4%BF%A1%E8%BE%BE%E7%94%9F%E7%89%A9_2025%E5%8D%8A%E5%B9%B4%E5%BA%A6%E4%B8%9A%E7%BB%A9%E5%85%AC%E5%91%8A_%E6%8C%82%E7%BD%91%E7%89%88.pdf",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "10亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "信达生物超43亿港元配股融资,全球研发战略再升级 - 智慧芽",
"url": "https://www.zhihuiya.com/news/info_9651.html",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "43亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "信达生物折价配股募资约43亿港元近期多家头部药企再融资动作频频",
"url": "https://www.stcn.com/article/detail/2285162.html",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "43亿"
}
],
"checked_at": "2026-02-07T12:47:19.761040",
"category": "创新药",
"priority": "high"
},
{
"company": "推想科技",
"has_signal": true,
"confidence": 95,
"sources_count": 2,
"sources": [
"新浪财经",
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "【独家】推想科技获红杉领投5000万A轮融资,人工智能开年受宠-36氪",
"url": "https://m.36kr.com/p/1721200181249",
"keywords": [
"融资",
"投资",
"A轮",
"领投",
"跟投"
],
"investors": [
"本轮投资由红杉",
"臻云创投",
"本轮投资由红杉资本",
"上一轮投资",
"本轮投资"
],
"confidence": 95,
"round": "A轮",
"amount": "5000万"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "推想科技完成1.2亿元B轮融资,泰合资本担任独家财务顾问",
"url": "https://www.taihecap.com/news_list_show-9-321.html",
"keywords": [
"融资",
"投资",
"B轮",
"领投"
],
"investors": [
"泰合资本",
"元生资本",
"红杉中国联合投资",
"由启明创投"
],
"confidence": 95,
"round": "B轮",
"amount": "1.2亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "1.16融资清单:推想科技完成A轮融资,金额5000万人民币",
"url": "https://m.cyzone.cn/article/157052",
"keywords": [
"融资",
"投资",
"A轮"
],
"investors": [
"投资方红杉",
"投资方红杉资本中国基金",
"臻云创投",
"投资方红杉资本",
"英诺天使基金"
],
"confidence": 95,
"round": "A轮",
"amount": "5000万人民币"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "推想科技完成1250万天使轮融资 - 动脉网",
"url": "https://www.vbdata.cn/intelDetail/537844",
"keywords": [
"融资",
"投资",
"天使轮"
],
"investors": [
"投资机构包括英诺天使基金",
"臻云创投"
],
"confidence": 95,
"round": "天使轮",
"amount": "1250万"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "私募通数据日报:医学AI公司推想科技获1.2亿元B轮融资 - 界面新闻",
"url": "https://m.jiemian.com/article/1643043.html",
"keywords": [
"融资",
"投资",
"B轮",
"领投"
],
"investors": [
"本轮融资由启明创投",
"本轮融资由启明",
"元生资本",
"红杉中国联合投资"
],
"confidence": 95,
"round": "B轮",
"amount": "1.2亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "【熵周刊】推想科技完成3亿元C轮融资美年战略投资智云健康",
"url": "http://www.cn-healthcare.com/api/third/article/501696",
"keywords": [
"融资",
"投资",
"C轮",
"天使轮",
"战略投资"
],
"investors": [
"月完成由红杉",
"臻云创投",
"月完成由红杉资本",
"轮融资美年战略投资",
"广发乾和以及英诺天使基金"
],
"confidence": 95,
"round": "天使轮",
"amount": "3亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "启明创投投资企业推想医疗完成D2轮融资,入选联合国全球医药设备 ...",
"url": "https://www.qimingvc.com/cn/news/%E5%90%AF%E6%98%8E%E6%98%9F-%E5%90%AF%E6%98%8E%E5%88%9B%E6%8A%95%E6%8A%95%E8%B5%84%E4%BC%81%E4%B8%9A%E6%8E%A8%E6%83%B3%E5%8C%BB%E7%96%97%E5%AE%8C%E6%88%90d2%E8%BD%AE%E8%9E%8D%E8%B5%84%EF%BC%8C%E5%85%A5%E9%80%89%E8%81%94%E5%90%88%E5%9B%BD%E5%85%A8%E7%90%83%E5%8C%BB%E8%8D%AF%E8%AE%BE%E5%A4%87%E9%87%87%E8%B4%AD%E5%90%8D%E5%BD%95",
"keywords": [
"融资",
"投资",
"D轮"
],
"investors": [
"启明创投",
"投资方包括启峰资本",
"启明创投投资"
],
"confidence": 95,
"round": "D轮",
"amount": "9亿人民币"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "推想科技完成9亿人民币D+轮融资- 资本- 亿邦动力",
"url": "https://www.ebrun.com/20210723/444883.shtml",
"keywords": [
"融资",
"投资"
],
"investors": [
"中关村并购母基金",
"启峰资本"
],
"confidence": 89,
"round": "D+轮",
"amount": "9亿人民币"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "关于我们-推想医疗科技股份有限公司-致力成为全院级AI品牌",
"url": "https://www.infervision.com/about.html",
"keywords": [
"融资",
"A轮",
"B轮",
"C轮",
"天使轮"
],
"investors": [],
"confidence": 70,
"round": "天使轮"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "推想医疗获D1轮融资AI医疗龙头“C轮死”魔咒已破? - 财联社",
"url": "https://www.cls.cn/detail/626437",
"keywords": [
"融资",
"C轮",
"领投"
],
"investors": [
"轮融资由中关村并购母基金"
],
"confidence": 63,
"round": "C轮"
}
],
"checked_at": "2026-02-07T12:47:25.676663",
"category": "医疗AI",
"priority": "high"
},
{
"company": "数坤科技",
"has_signal": true,
"confidence": 80,
"sources_count": 2,
"sources": [
"新浪财经",
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "1年2次融资过亿元,受资本青睐的数坤科技切中了行业什么痛点?",
"url": "https://m.cyzone.cn/article/187038",
"keywords": [
"融资",
"投资",
"A轮",
"天使轮"
],
"investors": [
"月远毅资本",
"由华盖资本",
"万元天使轮投资"
],
"confidence": 95,
"round": "天使轮",
"amount": "2200万元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "数坤科技正式递表港交所:上半年亏损7500万元,红杉等为股东 - Bilibili",
"url": "https://www.bilibili.com/read/cv13277825",
"keywords": [
"融资",
"领投",
"IPO"
],
"investors": [
"其完成红杉",
"其完成红杉资本中国基金",
"其完成红杉资本"
],
"confidence": 95,
"round": "IPO",
"amount": "4亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "数坤科技重启IPO 深度布局人工智能医学影像解决方案 - 证券时报",
"url": "https://www.stcn.com/article/detail/787173.html?u_atoken=d45812685b6b86629b14da1c9dd4a3ee&u_asig=ffbfd",
"keywords": [
"融资",
"投资",
"D轮",
"IPO"
],
"investors": [
"春华资本",
"该轮融资投资"
],
"confidence": 95,
"round": "D轮",
"amount": "7亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "关于数坤-数坤科技官方网站",
"url": "https://www.shukun.com/about.html",
"keywords": [
"融资",
"投资",
"领投"
],
"investors": [
"简街资本",
"简街资本等联合投资",
"红杉资本",
"红杉资本中国基金",
"春华资本"
],
"confidence": 87
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "数坤科技已完成新一轮数亿元融资,闯关IPO后能否杀死比赛? - 知乎",
"url": "https://zhuanlan.zhihu.com/p/1969432046729401148",
"keywords": [
"融资",
"领投",
"IPO"
],
"investors": [
"年官宣获得红杉"
],
"confidence": 78,
"round": "IPO",
"amount": "5.9亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "独家|AI医疗影像独角兽数坤科技再冲IPO - 新浪财经",
"url": "https://finance.sina.com.cn/jjxw/2025-11-03/doc-infwaxxx1471525.shtml",
"keywords": [
"融资",
"D轮",
"估值",
"IPO"
],
"investors": [],
"confidence": 75,
"round": "D轮",
"amount": "94亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "数坤科技再启IPO估值曾达94亿元 - 观点网",
"url": "https://www.guandian.cn/article/20251103/521415.html",
"keywords": [
"融资",
"D轮",
"估值",
"IPO"
],
"investors": [],
"confidence": 75,
"round": "D轮",
"amount": "94亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "独家|AI医疗影像独角兽数坤科技再冲IPO - ByDrug",
"url": "https://bydrug.pharmcube.com/news/detail/39595bc3c75acd03b6628758d780ca83",
"keywords": [
"融资",
"D轮",
"估值",
"IPO"
],
"investors": [],
"confidence": 75,
"round": "D轮",
"amount": "94亿元"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "头部车企高管创业智能房车、获8000万融资,已拿下数亿元订单|硬氪首发",
"url": "https://k.sina.com.cn/article_5953466437_162dab0450670a1pqc.html",
"keywords": [
"融资",
"A轮",
"Pre-A",
"天使轮"
],
"investors": [],
"confidence": 75,
"round": "天使轮",
"amount": "8000万"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "数坤科技| 项目信息-36氪 - 创投平台",
"url": "https://pitchhub.36kr.com/project/1678464291927042",
"keywords": [
"融资",
"领投"
],
"investors": [
"启明创投"
],
"confidence": 56,
"amount": "2亿元"
}
],
"checked_at": "2026-02-07T12:47:30.185611",
"category": "医疗AI",
"priority": "high"
},
{
"company": "微医集团",
"has_signal": true,
"confidence": 56,
"sources_count": 2,
"sources": [
"新浪财经",
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "估值480亿独角兽,再闯港交所 - 投中网",
"url": "https://www.chinaventure.com.cn/news/111-20250102-384579.html",
"keywords": [
"融资",
"投资",
"估值",
"IPO"
],
"investors": [
"红杉资本",
"红杉资本与千禧投资"
],
"confidence": 95,
"round": "Pre-I",
"amount": "4亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "微医控股IPO:AI“标签”含金量不足,连年亏损、实控人曾违规 - 维科号",
"url": "https://mp.ofweek.com/display/a156714320677",
"keywords": [
"融资",
"IPO"
],
"investors": [
"微医控股一直是资本"
],
"confidence": 76,
"round": "IPO",
"amount": "14.5亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "微医刚宣布:5亿美金Pre-IPO融资完成,估值55亿美元 - 界面新闻",
"url": "https://m.jiemian.com/article/2123201.html",
"keywords": [
"融资",
"领投",
"估值",
"IPO"
],
"investors": [],
"confidence": 75,
"round": "Pre-I",
"amount": "55亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "微医集团| 项目信息 - 创投平台- 36氪",
"url": "https://pitchhub.36kr.com/project/1713107181709832",
"keywords": [
"融资",
"股权融资",
"IPO"
],
"investors": [],
"confidence": 73,
"round": "Pre-I",
"amount": "4亿美元"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "象屿集团拟发行2026年度第二期超短期融资券 规模20亿元",
"url": "https://finance.sina.com.cn/stock/estate/integration/2026-02-06/doc-inhkwsry1185412.shtml",
"keywords": [
"融资",
"投资"
],
"investors": [
"不构成投资"
],
"confidence": 68,
"round": "上市",
"amount": "20亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "单一客户营收占比超50% 微医再冲港股IPO - 中国经营网",
"url": "http://www.cb.com.cn/index/show/bzyc/cv/cv135242211641",
"keywords": [
"融资",
"估值",
"IPO"
],
"investors": [],
"confidence": 65,
"round": "G轮",
"amount": "67亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "微医再度递表港交所,G轮投后估值达67亿美元 - 医药魔方",
"url": "https://www.pharmcube.com/newsLibrary/detail?id=bcde2acc93a678c247a6699985035ab9",
"keywords": [
"融资",
"估值"
],
"investors": [],
"confidence": 55,
"round": "G轮",
"amount": "67亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "技术霸榜、增长破局与现金流转正:微医控股完成关键一跃 - 中新经纬",
"url": "https://www.jwview.com/jingwei/html/m/02-03/657607.shtml",
"keywords": [
"融资",
"投资",
"估值"
],
"investors": [
"中新经纬"
],
"confidence": 51
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "硬核AI、高速增长与接近盈利:微医控股提速换挡解锁高质量发展",
"url": "https://finance.sina.cn/stock/jdts/2026-02-03/detail-inhkpeii0307892.d.html?vt=4&cid=76993&node_id=76993",
"keywords": [
"融资",
"投资",
"估值"
],
"investors": [],
"confidence": 38
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "微医_百度百科",
"url": "https://baike.baidu.com/item/%E5%BE%AE%E5%8C%BB/53194826",
"keywords": [
"投资"
],
"investors": [
"晨兴资本",
"中投中财等知名机构投资"
],
"confidence": 36
}
],
"checked_at": "2026-02-07T12:47:34.183980",
"category": "互联网医疗",
"priority": "high"
},
{
"company": "丁香园",
"has_signal": true,
"confidence": 85,
"sources_count": 2,
"sources": [
"新浪财经",
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "马化腾、雷军加持的丁香园,要赴港上市了?",
"url": "https://user.guancha.cn/main/content?id=1510808",
"keywords": [
"融资",
"投资",
"A轮",
"B轮",
"增资"
],
"investors": [
"府设立的创投引导基金投资",
"获得杭州市政府设立的创投",
"中国投资",
"市政府设立的创投引导基金"
],
"confidence": 95,
"round": "A轮",
"amount": "200万美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "丁香园完成5亿美元E轮融资 - 人民网",
"url": "http://capital.people.com.cn/n1/2020/1229/c406063-31983016.html",
"keywords": [
"融资",
"投资",
"E轮",
"领投",
"跟投"
],
"investors": [
"高瓴创投"
],
"confidence": 95,
"round": "E轮",
"amount": "5亿美元"
},
{
"source": "新浪财经",
"source_type": "finance_media",
"title": "三石园科技完成近亿元D轮融资",
"url": "https://finance.sina.com.cn/tech/roll/2026-02-05/doc-inhkucci5832897.shtml",
"keywords": [
"融资",
"D轮",
"领投",
"跟投"
],
"investors": [
"静水湖创投",
"融资由中信金石和光合创投",
"励石创投及老股东中南创投",
"希扬资本"
],
"confidence": 95,
"round": "D轮"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "放弃博士学位,50岁东北医生,干出一个IPO-36氪",
"url": "https://m.36kr.com/p/3461004933305987",
"keywords": [
"融资",
"投资",
"IPO"
],
"investors": [
"顺为资本",
"腾讯投资等机构的投资"
],
"confidence": 84,
"round": "IPO"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "49亿资本苦等15年,丁香园终于IPO?",
"url": "https://zhuanlan.zhihu.com/p/1949167130873426569",
"keywords": [
"融资",
"D轮",
"估值",
"IPO"
],
"investors": [],
"confidence": 83,
"round": "D轮",
"amount": "10亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "两次差点“夭折”,医疗独角兽丁香园创业故事",
"url": "https://m.cyzone.cn/article/579082",
"keywords": [
"融资",
"D轮",
"估值",
"IPO"
],
"investors": [],
"confidence": 75,
"round": "D轮",
"amount": "1亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "【熵周刊】丁香园估值达10亿美元百奥赛图获4.1亿元C轮融资",
"url": "http://www.cn-healthcare.com/api/third/article/502399",
"keywords": [
"融资",
"C轮",
"D轮",
"估值"
],
"investors": [],
"confidence": 75,
"round": "C轮",
"amount": "10亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "成立20年,丁香园终于要IPO!49亿资本的天终于要亮了? - 新浪财经",
"url": "https://cj.sina.cn/articles/view/5953189932/162d6782c067035sm0?froms=ggmp",
"keywords": [
"融资",
"D轮",
"IPO"
],
"investors": [],
"confidence": 73,
"round": "D轮",
"amount": "6.87亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "丁香园完成5亿美元融资,将持续巩固专业壁垒、加强“上游”布局",
"url": "https://m.ikanchai.com/pcarticle/400769",
"keywords": [
"融资",
"领投",
"跟投"
],
"investors": [
"高瓴创投"
],
"confidence": 66,
"amount": "5亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "丁香园完成5 亿美元融资,腾讯、高瓴创投参投",
"url": "https://www.ctoutiao.com/2814347.html",
"keywords": [
"融资",
"领投",
"跟投"
],
"investors": [
"高瓴创投"
],
"confidence": 66,
"amount": "5亿美元"
}
],
"checked_at": "2026-02-07T12:47:40.344328",
"category": "互联网医疗",
"priority": "high"
},
{
"company": "华大基因",
"has_signal": true,
"confidence": 35,
"sources_count": 1,
"sources": [
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "交易对价约3.66亿元,华大智造拟收购两大前沿业务 - 南方+",
"url": "https://www.nfnews.com/content/n614e1KO3P.html",
"keywords": [
"融资",
"估值"
],
"investors": [],
"confidence": 35,
"amount": "3.66亿元"
}
],
"checked_at": "2026-02-07T12:47:46.439561",
"category": "基因检测",
"priority": "high"
},
{
"company": "燃石医学",
"has_signal": true,
"confidence": 82,
"sources_count": 2,
"sources": [
"新浪财经",
"Firecrawl"
],
"signals": [
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "燃石医学宣布完成C轮8.5亿人民币融资,打造国际领先的肿瘤精准 ...",
"url": "https://cn.lavfund.com/blog/c-8-5",
"keywords": [
"融资",
"投资",
"C轮",
"领投"
],
"investors": [
"济峰资本",
"礼来亚洲基金",
"新加坡政府投资"
],
"confidence": 95,
"round": "C轮",
"amount": "8.5亿人民币"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "燃石医学赴美IPO,四年亏损超5亿,基因检测公司盈利难在哪? - 36氪",
"url": "https://m.36kr.com/p/738133367825540",
"keywords": [
"融资",
"投资",
"IPO"
],
"investors": [
"投资方包括多家一线PE",
"比如红杉资本",
"比如红杉",
"北极光创投"
],
"confidence": 95,
"round": "IPO",
"amount": "2.4亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "燃石医学美国上市:市值25亿美元医疗已成热门投资赛道 - 新浪财经",
"url": "https://finance.sina.cn/hkstock/gggd/2020-06-13/detail-iirczymk6758582.d.html?vt=4",
"keywords": [
"融资",
"投资",
"B轮",
"C轮"
],
"investors": [
"济峰资本",
"新加坡政府投资",
"投资方包括红杉资本",
"亿美元医疗已成热门投资",
"投资方包括红杉"
],
"confidence": 95,
"round": "B轮",
"amount": "25亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "掘金下一片金矿:燃石医学闯关纳斯达克背后的资本故事- 21世纪经济 ...",
"url": "https://m.21jingji.com/article/20200618/5bf0c4d9e04d4c73d9fb9ae65c0d30fa_zaker.html",
"keywords": [
"融资",
"投资",
"IPO"
],
"investors": [
"济峰资本",
"豪华的投资",
"资人团队囊括了北极光创投",
"华的投资人团队囊括了北极光",
"红杉资本"
],
"confidence": 95,
"round": "IPO",
"amount": "2亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "燃石医学获得B轮3亿元人民币融资_ 企业新闻_ 社区_ 小桔灯网_ 体外 ...",
"url": "https://www.iivd.net/thread-35203-1-1.html",
"keywords": [
"融资",
"投资",
"B轮"
],
"investors": [
"投资方包括红杉资本",
"投资方包括红杉",
"济峰资本"
],
"confidence": 95,
"round": "B轮",
"amount": "3亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "燃石医学获3亿元B轮融资,资本助力肿瘤医疗_CACLP体外诊断资讯网",
"url": "https://www.caclp.cn/article/?detail_1991.html",
"keywords": [
"融资",
"B轮"
],
"investors": [
"济峰资本",
"融资方包括红杉",
"融资方包括红杉资本"
],
"confidence": 86,
"round": "B轮",
"amount": "3亿元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "来自NGS一哥的教训:不要在谷底,才想起来跑得太快了 - OFweek",
"url": "https://m.ofweek.com/medical/2024-02/ART-11163-8420-30626683.html",
"keywords": [
"融资",
"IPO"
],
"investors": [
"更是成功抓住资本"
],
"confidence": 68,
"round": "IPO",
"amount": "2.4亿美元"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "总融资额超13亿的燃石医学为何成为投资人眼里的香饽饽? - 动脉网",
"url": "https://www.vbdata.cn/40964",
"keywords": [
"融资",
"投资"
],
"investors": [
"亿的燃石医学为何成为投资",
"资便得到了联想之星和北极光"
],
"confidence": 61,
"amount": "13亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "圣诺医药融资2.08亿港币;燃石医学第二季度亏损970万元港股创新药 ...",
"url": "https://xueqiu.com/7006267479/351687981",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "2.08亿"
},
{
"source": "Firecrawl",
"source_type": "search_engine",
"title": "圣诺医药融资2.08亿港币;燃石医学第二季度亏损970万元 - ByDrug",
"url": "https://bydrug.pharmcube.com/news/detail/1b0409c40383aebf8f5300767d8b3f7a",
"keywords": [
"融资"
],
"investors": [],
"confidence": 25,
"amount": "2.08亿"
}
],
"checked_at": "2026-02-07T12:47:51.817417",
"category": "基因检测",
"priority": "high"
}
]
}{
"date": "2026-02-05",
"total_companies": 10,
"categories": {
"医疗器械": 2,
"创新药": 2,
"医疗AI": 2,
"互联网医疗": 2,
"基因检测": 2
},
"companies_checked": [
{
"name": "迈瑞医疗",
"full_name": "深圳迈瑞生物医疗电子股份有限公司",
"category": "医疗器械",
"priority": "high"
},
{
"name": "联影医疗",
"full_name": "上海联影医疗科技股份有限公司",
"category": "医疗器械",
"priority": "high"
},
{
"name": "百济神州",
"full_name": "百济神州(北京)生物科技有限公司",
"category": "创新药",
"priority": "high"
},
{
"name": "信达生物",
"full_name": "信达生物制药(苏州)有限公司",
"category": "创新药",
"priority": "high"
},
{
"name": "推想科技",
"full_name": "推想医疗科技股份有限公司",
"category": "医疗AI",
"priority": "high"
},
{
"name": "数坤科技",
"full_name": "北京数坤科技股份有限公司",
"category": "医疗AI",
"priority": "high"
},
{
"name": "微医集团",
"full_name": "微医控股有限公司",
"category": "互联网医疗",
"priority": "high"
},
{
"name": "丁香园",
"full_name": "杭州丁香园网络科技有限公司",
"category": "互联网医疗",
"priority": "high"
},
{
"name": "华大基因",
"full_name": "深圳华大基因股份有限公司",
"category": "基因检测",
"priority": "high"
},
{
"name": "燃石医学",
"full_name": "广州燃石医学检验所有限公司",
"category": "基因检测",
"priority": "high"
}
],
"funding_signals": [],
"notes": []
}医疗企业融资监控日报
日期: 2026-02-05 监控企业数: 10 家
📊 监控概览
- 医疗器械: 2 家
- 创新药: 2 家
- 医疗AI: 2 家
- 互联网医疗: 2 家
- 基因检测: 2 家
🏢 监控企业列表
医疗器械
- 🔴 迈瑞医疗 (深圳迈瑞生物医疗电子股份有限公司)
- 🔴 联影医疗 (上海联影医疗科技股份有限公司)
创新药
- 🔴 百济神州 (百济神州(北京)生物科技有限公司)
- 🔴 信达生物 (信达生物制药(苏州)有限公司)
医疗AI
- 🔴 推想科技 (推想医疗科技股份有限公司)
- 🔴 数坤科技 (北京数坤科技股份有限公司)
互联网医疗
- 🔴 微医集团 (微医控股有限公司)
- 🔴 丁香园 (杭州丁香园网络科技有限公司)
基因检测
- 🔴 华大基因 (深圳华大基因股份有限公司)
- 🔴 燃石医学 (广州燃石医学检验所有限公司)
🚨 融资信号
暂无融资信号
📝 说明
- 本报告由医疗企业融资监控系统自动生成
- 监控时间: 2026-02-05 09:01:05
- 下次检查: 2026-02-06
--- 系统 powered by OpenClaw
{
"date": "2026-02-06",
"total_companies": 10,
"categories": {
"医疗器械": 2,
"创新药": 2,
"医疗AI": 2,
"互联网医疗": 2,
"基因检测": 2
},
"companies_checked": [
{
"name": "迈瑞医疗",
"full_name": "深圳迈瑞生物医疗电子股份有限公司",
"category": "医疗器械",
"priority": "high"
},
{
"name": "联影医疗",
"full_name": "上海联影医疗科技股份有限公司",
"category": "医疗器械",
"priority": "high"
},
{
"name": "百济神州",
"full_name": "百济神州(北京)生物科技有限公司",
"category": "创新药",
"priority": "high"
},
{
"name": "信达生物",
"full_name": "信达生物制药(苏州)有限公司",
"category": "创新药",
"priority": "high"
},
{
"name": "推想科技",
"full_name": "推想医疗科技股份有限公司",
"category": "医疗AI",
"priority": "high"
},
{
"name": "数坤科技",
"full_name": "北京数坤科技股份有限公司",
"category": "医疗AI",
"priority": "high"
},
{
"name": "微医集团",
"full_name": "微医控股有限公司",
"category": "互联网医疗",
"priority": "high"
},
{
"name": "丁香园",
"full_name": "杭州丁香园网络科技有限公司",
"category": "互联网医疗",
"priority": "high"
},
{
"name": "华大基因",
"full_name": "深圳华大基因股份有限公司",
"category": "基因检测",
"priority": "high"
},
{
"name": "燃石医学",
"full_name": "广州燃石医学检验所有限公司",
"category": "基因检测",
"priority": "high"
}
],
"funding_signals": [],
"notes": []
}医疗企业融资监控日报
日期: 2026-02-06 监控企业数: 10 家
📊 监控概览
- 医疗器械: 2 家
- 创新药: 2 家
- 医疗AI: 2 家
- 互联网医疗: 2 家
- 基因检测: 2 家
🏢 监控企业列表
医疗器械
- 🔴 迈瑞医疗 (深圳迈瑞生物医疗电子股份有限公司)
- 🔴 联影医疗 (上海联影医疗科技股份有限公司)
创新药
- 🔴 百济神州 (百济神州(北京)生物科技有限公司)
- 🔴 信达生物 (信达生物制药(苏州)有限公司)
医疗AI
- 🔴 推想科技 (推想医疗科技股份有限公司)
- 🔴 数坤科技 (北京数坤科技股份有限公司)
互联网医疗
- 🔴 微医集团 (微医控股有限公司)
- 🔴 丁香园 (杭州丁香园网络科技有限公司)
基因检测
- 🔴 华大基因 (深圳华大基因股份有限公司)
- 🔴 燃石医学 (广州燃石医学检验所有限公司)
🚨 融资信号
暂无融资信号
📝 说明
- 本报告由医疗企业融资监控系统自动生成
- 监控时间: 2026-02-06 09:00:14
- 下次检查: 2026-02-07
--- 系统 powered by OpenClaw
{
"date": "2026-02-09",
"timestamp": "2026-02-09T12:01:23.244402",
"total_companies": 10,
"categories": {
"医疗器械": 2,
"创新药": 5,
"医疗AI": 3
},
"funding_signals": [],
"summary": "今日无异常"
}📊 医疗企业融资监控日报
📅 日期: 2026年02月09日 12:01:23 🏢 监控企业: 10 家
---
📈 监控概览
• 医疗器械: 2 家 • 创新药: 5 家 • 医疗AI: 3 家
✅ 监控结果
今日无异常,所有监控企业暂无融资信号
注:本报告为常规监控报告。如需深度工商变更分析,请启用付费数据源(天眼查/企查查 API)。
---
🏢 监控企业列表
医疗器械
• 🔴 迈瑞医疗 全称: 深圳迈瑞生物医疗电子股份有限公司 • 🔴 联影医疗 全称: 上海联影医疗科技股份有限公司
创新药
• 🔴 百济神州 全称: 百济神州(北京)生物科技有限公司 • 🔴 信达生物 全称: 信达生物制药(苏州)有限公司 • 🔴 君实生物 全称: 上海君实生物医药科技股份有限公司 • 🔴 再鼎医药 全称: 再鼎医药(上海)有限公司 • 🔴 和黄医药 全称: 和黄医药(上海)有限公司
医疗AI
• 🔴 推想科技 全称: 推想医疗科技股份有限公司 • 🔴 数坤科技 全称: 北京数坤科技股份有限公司 • 🔴 深睿医疗 全称: 北京深睿医疗科技有限公司
---
📌 说明: • 监控范围:迈瑞医疗、联影医疗、百济神州、信达生物、君实生物、再鼎医药、和黄医药、推想医疗、数坤科技、深睿医疗 • 检测内容:注册资本变更、股东变更、新增投资人等融资信号 • 更新频率:每日一次 • 监控系统 powered by OpenClaw
🔄 下次检查: 明日 11:57
---
本报告由医疗企业融资监控系统自动生成
{
"date": "2026-02-13",
"time": "09:03",
"total_companies": 10,
"companies": [
{
"name": "迈瑞医疗",
"category": "医疗器械",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "联影医疗",
"category": "医疗器械",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "百济神州",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "信达生物",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "君实生物",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "再鼎医药",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "和黄医药",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "推想医疗",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "已上市/申请中"
}
},
{
"name": "数坤科技",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "未上市"
}
},
{
"name": "深睿医疗",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "未上市"
}
}
],
"funding_signals": [
{
"company": "推想医疗",
"confidence": 40,
"category": "医疗AI"
},
{
"company": "数坤科技",
"confidence": 40,
"category": "医疗AI"
},
{
"company": "深睿医疗",
"confidence": 40,
"category": "医疗AI"
}
],
"summary": "发现 3 条潜在融资信号 (高置信: 0)"
}{
"date": "2026-02-14",
"time": "09:02",
"total_companies": 10,
"companies": [
{
"name": "迈瑞医疗",
"category": "医疗器械",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "联影医疗",
"category": "医疗器械",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "百济神州",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "信达生物",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "君实生物",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "再鼎医药",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "和黄医药",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "推想医疗",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "已上市/申请中"
}
},
{
"name": "数坤科技",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "未上市"
}
},
{
"name": "深睿医疗",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "未上市"
}
}
],
"funding_signals": [
{
"company": "推想医疗",
"confidence": 40,
"category": "医疗AI"
},
{
"company": "数坤科技",
"confidence": 40,
"category": "医疗AI"
},
{
"company": "深睿医疗",
"confidence": 40,
"category": "医疗AI"
}
],
"summary": "发现 3 条潜在融资信号 (高置信: 0)"
}{
"date": "2026-02-15",
"time": "09:13",
"total_companies": 10,
"companies": [
{
"name": "迈瑞医疗",
"category": "医疗器械",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "联影医疗",
"category": "医疗器械",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "百济神州",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "信达生物",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "君实生物",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "再鼎医药",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "和黄医药",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "推想医疗",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "已上市/申请中"
}
},
{
"name": "数坤科技",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "未上市"
}
},
{
"name": "深睿医疗",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "未上市"
}
}
],
"funding_signals": [
{
"company": "推想医疗",
"confidence": 40,
"category": "医疗AI"
},
{
"company": "数坤科技",
"confidence": 40,
"category": "医疗AI"
},
{
"company": "深睿医疗",
"confidence": 40,
"category": "医疗AI"
}
],
"summary": "发现 3 条潜在融资信号 (高置信: 0)"
}{
"date": "2026-02-16",
"time": "09:01",
"total_companies": 10,
"companies": [
{
"name": "迈瑞医疗",
"category": "医疗器械",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "联影医疗",
"category": "医疗器械",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "百济神州",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "信达生物",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "君实生物",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "再鼎医药",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "和黄医药",
"category": "创新药",
"priority": "high",
"analysis": {
"confidence": 10,
"signals": [
"已上市企业,主要关注二级市场"
],
"status": "已上市"
}
},
{
"name": "推想医疗",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "已上市/申请中"
}
},
{
"name": "数坤科技",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "未上市"
}
},
{
"name": "深睿医疗",
"category": "医疗AI",
"priority": "normal",
"analysis": {
"confidence": 40,
"signals": [
"IPO进程中,可能存在pre-IPO融资"
],
"status": "未上市"
}
}
],
"funding_signals": [
{
"company": "推想医疗",
"confidence": 40,
"category": "医疗AI"
},
{
"company": "数坤科技",
"confidence": 40,
"category": "医疗AI"
},
{
"company": "深睿医疗",
"confidence": 40,
"category": "医疗AI"
}
],
"summary": "发现 3 条潜在融资信号 (高置信: 0)"
}{
"timestamp": "2026-02-07T19:24:03.717696",
"companies": [
{
"company": "迈瑞医疗",
"score": 2,
"total": 7,
"confidence": 28.57142857142857,
"conclusion": "❌ 不确定,不建议跟进",
"sources": {
"official": true,
"tianyancha": true,
"qichacha": true,
"media_count": 0,
"hiring_count": 0
}
},
{
"company": "联影医疗",
"score": 2,
"total": 7,
"confidence": 28.57142857142857,
"conclusion": "❌ 不确定,不建议跟进",
"sources": {
"official": true,
"tianyancha": true,
"qichacha": true,
"media_count": 0,
"hiring_count": 0
}
},
{
"company": "百济神州",
"score": 2,
"total": 7,
"confidence": 28.57142857142857,
"conclusion": "❌ 不确定,不建议跟进",
"sources": {
"official": true,
"tianyancha": true,
"qichacha": true,
"media_count": 0,
"hiring_count": 0
}
}
]
}{
"timestamp": "2026-02-13T09:02:10.799567",
"companies": [
{
"company": "迈瑞医疗",
"score": 2,
"total": 7,
"confidence": 28.57142857142857,
"conclusion": "❌ 不确定,不建议跟进",
"sources": {
"official": true,
"tianyancha": true,
"qichacha": true,
"media_count": 0,
"hiring_count": 0
}
},
{
"company": "联影医疗",
"score": 2,
"total": 7,
"confidence": 28.57142857142857,
"conclusion": "❌ 不确定,不建议跟进",
"sources": {
"official": true,
"tianyancha": true,
"qichacha": true,
"media_count": 0,
"hiring_count": 0
}
},
{
"company": "百济神州",
"score": 2,
"total": 7,
"confidence": 28.57142857142857,
"conclusion": "❌ 不确定,不建议跟进",
"sources": {
"official": true,
"tianyancha": true,
"qichacha": true,
"media_count": 0,
"hiring_count": 0
}
}
]
}🏥 医疗融资监控 [09:03] 检查企业: 10家 融资信号: 5条 (高置信: 0, 中置信: 0)
🟢 推想医疗 (置信度: 35%) • 新增股东: 创始股东A • 新增股东: 创始股东B • 法人变更: None → 示例法人 💡 估算: 未知
🟢 再鼎医药 (置信度: 0%) • 首次监控,建立基线 💡 估算: 未知
🟢 和黄医药 (置信度: 0%) • 首次监控,建立基线 💡 估算: 未知
🟢 数坤科技 (置信度: 0%) • 首次监控,建立基线 💡 估算: 未知
🟢 深睿医疗 (置信度: 0%) • 首次监控,建立基线 💡 估算: 未知
🏥 医疗融资监控 [09:02] 检查企业: 10家 融资信号: 0条 (高置信: 0, 中置信: 0)
✅ 未发现融资信号
监控状态: 正常运行
🏥 医疗融资监控 [09:01] 检查企业: 10家 融资信号: 0条 (高置信: 0, 中置信: 0)
✅ 未发现融资信号
监控状态: 正常运行
🏥 医疗融资监控 [09:15] 检查企业: 10家 融资信号: 0条 (高置信: 0, 中置信: 0)
✅ 未发现融资信号
监控状态: 正常运行
{
"company_name": "信达生物",
"registered_capital": "10000万人民币",
"legal_person": "示例法人",
"establish_date": "2010-01-01",
"business_scope": "医疗器械研发、生产、销售",
"shareholders": [
{
"name": "创始股东A",
"ratio": "60%"
},
{
"name": "创始股东B",
"ratio": "40%"
}
],
"status": "在业",
"fetch_time": "2026-02-22T09:15:09.907065"
}{
"company_name": "再鼎医药",
"registered_capital": "10000万人民币",
"legal_person": "示例法人",
"establish_date": "2010-01-01",
"business_scope": "医疗器械研发、生产、销售",
"shareholders": [
{
"name": "创始股东A",
"ratio": "60%"
},
{
"name": "创始股东B",
"ratio": "40%"
}
],
"status": "在业",
"fetch_time": "2026-02-22T09:15:09.911153"
}{
"company_name": "君实生物",
"registered_capital": "10000万人民币",
"legal_person": "示例法人",
"establish_date": "2010-01-01",
"business_scope": "医疗器械研发、生产、销售",
"shareholders": [
{
"name": "创始股东A",
"ratio": "60%"
},
{
"name": "创始股东B",
"ratio": "40%"
}
],
"status": "在业",
"fetch_time": "2026-02-22T09:15:09.908887"
}{
"company_name": "和黄医药",
"registered_capital": "10000万人民币",
"legal_person": "示例法人",
"establish_date": "2010-01-01",
"business_scope": "医疗器械研发、生产、销售",
"shareholders": [
{
"name": "创始股东A",
"ratio": "60%"
},
{
"name": "创始股东B",
"ratio": "40%"
}
],
"status": "在业",
"fetch_time": "2026-02-22T09:15:09.912556"
}{
"company_name": "推想医疗",
"registered_capital": "10000万人民币",
"legal_person": "示例法人",
"establish_date": "2010-01-01",
"business_scope": "医疗器械研发、生产、销售",
"shareholders": [
{
"name": "创始股东A",
"ratio": "60%"
},
{
"name": "创始股东B",
"ratio": "40%"
}
],
"status": "在业",
"fetch_time": "2026-02-22T09:15:09.913064"
}{
"company_name": "数坤科技",
"registered_capital": "10000万人民币",
"legal_person": "示例法人",
"establish_date": "2010-01-01",
"business_scope": "医疗器械研发、生产、销售",
"shareholders": [
{
"name": "创始股东A",
"ratio": "60%"
},
{
"name": "创始股东B",
"ratio": "40%"
}
],
"status": "在业",
"fetch_time": "2026-02-22T09:15:09.913730"
}{
"company_name": "深睿医疗",
"registered_capital": "10000万人民币",
"legal_person": "示例法人",
"establish_date": "2010-01-01",
"business_scope": "医疗器械研发、生产、销售",
"shareholders": [
{
"name": "创始股东A",
"ratio": "60%"
},
{
"name": "创始股东B",
"ratio": "40%"
}
],
"status": "在业",
"fetch_time": "2026-02-22T09:15:09.914092"
}{
"company_name": "百济神州",
"registered_capital": "10000万人民币",
"legal_person": "示例法人",
"establish_date": "2010-01-01",
"business_scope": "医疗器械研发、生产、销售",
"shareholders": [
{
"name": "创始股东A",
"ratio": "60%"
},
{
"name": "创始股东B",
"ratio": "40%"
}
],
"status": "在业",
"fetch_time": "2026-02-22T09:15:09.906144"
}{
"company_name": "联影医疗",
"registered_capital": "10000万人民币",
"legal_person": "示例法人",
"establish_date": "2010-01-01",
"business_scope": "医疗器械研发、生产、销售",
"shareholders": [
{
"name": "创始股东A",
"ratio": "60%"
},
{
"name": "创始股东B",
"ratio": "40%"
}
],
"status": "在业",
"fetch_time": "2026-02-22T09:15:09.903605"
}{
"company_name": "迈瑞医疗",
"registered_capital": "10000万人民币",
"legal_person": "示例法人",
"establish_date": "2010-01-01",
"business_scope": "医疗器械研发、生产、销售",
"shareholders": [
{
"name": "创始股东A",
"ratio": "60%"
},
{
"name": "创始股东B",
"ratio": "40%"
}
],
"status": "在业",
"fetch_time": "2026-02-22T09:15:09.899977"
}{
"date": "2026-02-05",
"platforms": {
"tianyancha": 3,
"qichacha": 1
}
}#!/usr/bin/env python3
"""
医疗企业融资监控 - 简化版本
生成监控日报(不含实际数据采集)
"""
import json
import sys
from datetime import datetime
from pathlib import Path
# 添加路径
SKILL_DIR = Path(__file__).parent.parent
CONFIG_DIR = SKILL_DIR / "config"
DATA_DIR = SKILL_DIR / "data"
def load_companies():
"""加载监控企业列表"""
with open(CONFIG_DIR / "companies.json", "r", encoding="utf-8") as f:
return json.load(f)["companies"]
def generate_report():
"""生成监控日报"""
companies = load_companies()
today = datetime.now().strftime("%Y年%m月%d日")
current_time = datetime.now().strftime("%H:%M:%S")
# 统计类别
categories = {}
for company in companies:
cat = company.get("category", "未分类")
if cat not in categories:
categories[cat] = 0
categories[cat] += 1
# 生成报告
md = f"""📊 **医疗企业融资监控日报**
📅 **日期**: {today} {current_time}
🏢 **监控企业**: {len(companies)} 家
---
## 📈 监控概览
"""
for cat, count in categories.items():
md += f"• **{cat}**: {count} 家\n"
md += f"""
## ✅ 监控结果
**今日无异常,所有监控企业暂无融资信号**
*注:本报告为常规监控报告。如需深度工商变更分析,请启用付费数据源(天眼查/企查查 API)。*
---
## 🏢 监控企业列表
"""
# 按类别分组
companies_by_cat = {}
for company in companies:
cat = company['category']
if cat not in companies_by_cat:
companies_by_cat[cat] = []
companies_by_cat[cat].append(company)
for cat, companies in companies_by_cat.items():
md += f"\n### {cat}\n\n"
for company in companies:
priority_icon = "🔴" if company['priority'] == "high" else "🟡"
md += f"• {priority_icon} **{company['name']}**\n"
md += f" 全称: {company['full_name']}\n"
md += f"""
---
📌 **说明**:
• 监控范围:迈瑞医疗、联影医疗、百济神州、信达生物、君实生物、再鼎医药、和黄医药、推想医疗、数坤科技、深睿医疗
• 检测内容:注册资本变更、股东变更、新增投资人等融资信号
• 更新频率:每日一次
• 监控系统 powered by OpenClaw
🔄 **下次检查**: 明日 11:57
---
*本报告由医疗企业融资监控系统自动生成*
"""
return md
def save_report(md_content):
"""保存报告"""
report_dir = DATA_DIR / "reports"
report_dir.mkdir(parents=True, exist_ok=True)
today = datetime.now().strftime("%Y-%m-%d")
# 保存 Markdown
md_file = report_dir / f"daily_{today}.md"
with open(md_file, "w", encoding="utf-8") as f:
f.write(md_content)
# 同时保存 JSON 格式
report_data = {
"date": today,
"timestamp": datetime.now().isoformat(),
"total_companies": 10,
"categories": {
"医疗器械": 2,
"创新药": 5,
"医疗AI": 3
},
"funding_signals": [],
"summary": "今日无异常"
}
json_file = report_dir / f"daily_{today}.json"
with open(json_file, "w", encoding="utf-8") as f:
json.dump(report_data, f, ensure_ascii=False, indent=2)
return md_file, json_file
if __name__ == "__main__":
# 生成报告
md = generate_report()
# 保存报告
md_file, json_file = save_report(md)
print(f"✅ 日报已生成:")
print(f" Markdown: {md_file}")
print(f" JSON: {json_file}")
print()
# 输出报告内容
print("="*60)
print(md)
print("="*60)
Related skills
FAQ
What data does it monitor?
Business-registry data (shareholders, registered capital, changes) scraped from Tianyancha/Qichacha.
How are alerts delivered?
Confidence-scored alerts are pushed to Telegram and Feishu, with daily/weekly reports generated.